BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/20/2021 2:13:53 AM | Browse: 503 | Download: 910
 |
Received |
|
2020-11-05 12:37 |
|
Peer-Review Started |
|
2020-11-05 12:37 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-11-30 19:16 |
|
Revised |
|
2021-01-04 17:13 |
|
Second Decision |
|
2021-02-06 07:17 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-02-18 20:01 |
|
Articles in Press |
|
2021-02-18 20:01 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-03-01 00:22 |
|
Publish the Manuscript Online |
|
2021-03-20 02:13 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Efficacy and safety of once daily tacrolimus compared to twice daily tacrolimus after liver transplantation
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Khalid Ibrahim Bzeizi, Ali Albenmousa, Mohamed Shawkat, Zidan Ahmed, Saleh Alabbad, Waleed Al-Hamoudi, Roberto Troisi and Deiter Broering |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Khalid Ibrahim Bzeizi, FRCP, Doctor, Doctor, Department of Liver Transplantation, King Faisal Specialist Hospital and Research Center, Zahrawi Street, Al Maather, Riyadh 12713, Saudi Arabia. kbzeizi@kfshrc.edu.sa |
| Key Words |
Prolonged release; Tacrolimus; Liver transplantation; Graft rejection; Renal impairment; FK level |
| Core Tip |
Tacrolimus, a calcineurin inhibitor is an important component of the immunosuppressive regimens post liver transplantation. Compliance to immunosuppression treatment generally is important and non-adherence is a major risk factor of graft rejection and loss. Compliance to medication declines over the course of time in patients after liver transplantation due to several factors and this contributes to about 20% of late acute rejection. The efficacy of once daily tacrolimus regimens has been reported in many studies and this systematic review/meta-analysis confirmed the evidence of comparable efficacy and safety of prolonged release tacrolimus to the twice daily immediate release formulation. |
| Publish Date |
2021-03-20 02:13 |
| Citation |
Bzeizi KI, Albenmousa A, Shawkat AM, Ahmed Z, Alabbad S, Alhamoudi W, Troisi R, Broering D. Efficacy and safety of once daily tacrolimus compared to twice daily tacrolimus after liver transplantation. World J Hepatol 2021; 13(3): 375-383 |
| URL |
https://www.wjgnet.com/1948-5182/full/v13/i3/375.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v13.i3.375 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
